John Newman
Stock Analyst at Canaccord Genuity
(4.01)
# 1,701
Out of 4,468 analysts
941
Total ratings
44.8%
Success rate
5.3%
Average return
Main Sectors:
Stocks Rated by John Newman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CMPX Compass Therapeutics | Maintained: Buy | $7 | $2.18 | +221.10% | 13 | Jul 1, 2026 | |
| MRKR Marker Therapeutics | Maintained: Buy | $8 | $1.45 | +451.72% | 13 | Jun 29, 2026 | |
| TNGX Tango Therapeutics | Maintained: Buy | $42 → $46 | $28.73 | +60.11% | 7 | Jun 29, 2026 | |
| TYRA Tyra Biosciences | Maintained: Buy | $50 | $29.41 | +70.01% | 7 | Jun 25, 2026 | |
| DCTH Delcath Systems | Maintained: Buy | $21 | $12.91 | +62.66% | 27 | Jun 17, 2026 | |
| NUVL Nuvalent | Downgraded: Hold | $126 | $123.60 | +1.94% | 14 | Jun 10, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Maintained: Buy | $23 | $7.80 | +194.87% | 2 | Jun 8, 2026 | |
| BNTX BioNTech SE | Maintained: Buy | $158 | $93.92 | +68.23% | 23 | Jun 1, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $1,057 → $875 | $624.72 | +40.06% | 117 | May 19, 2026 | |
| CADL Candel Therapeutics | Maintained: Buy | $25 | $9.88 | +153.04% | 12 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $8.62 | +108.82% | 26 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $2.11 | +563.51% | 37 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $1.30 | +592.31% | 2 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $11.37 | +14.34% | 90 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $15.38 | +147.07% | 11 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $7.94 | +177.08% | 67 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.9007 | n/a | 19 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $4.18 | n/a | 18 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $300 | $10.33 | n/a | 34 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 | $10.18 | n/a | 45 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $639.62 → $255.85 | $2.14 | n/a | 40 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 → $44 | $37.08 | n/a | 57 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $3 | $0.0058 | n/a | 24 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $352.92 | $17.60 | n/a | 2 | May 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $24.50 | n/a | 1 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $10.78 | n/a | 25 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.978 | n/a | 12 | Mar 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14.21 | $9.43 | n/a | 1 | Mar 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $2.43 | n/a | 18 | Jun 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $6 | $1.45 | n/a | 18 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $5 | $60.30 | n/a | 17 | Jun 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $15.80 | n/a | 10 | Mar 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $17.08 | n/a | 11 | Mar 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $14.81 | n/a | 12 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $60 | $2.11 | n/a | 13 | Nov 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $15 | $2.46 | n/a | 4 | Oct 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $13.81 | n/a | 17 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $6.06 | n/a | 9 | Jul 26, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $90 | $30.33 | n/a | 1 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $3.52 | n/a | 1 | May 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $32.65 | n/a | 1 | May 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $1,032.28 | n/a | 1 | Mar 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $6 | $1.05 | n/a | 5 | Mar 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $201 | $237.51 | n/a | 5 | Mar 3, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $5.19 | n/a | 1 | Jan 7, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $9 | $6.89 | n/a | 3 | Oct 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $127 | $209.74 | n/a | 45 | Dec 20, 2011 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $5 | $4.05 | n/a | 2 | Mar 15, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $81.58 | n/a | 1 | Jun 10, 2009 |
Compass Therapeutics
Jul 1, 2026
Maintained: Buy
Price Target: $7
Current: $2.18
Upside: +221.10%
Marker Therapeutics
Jun 29, 2026
Maintained: Buy
Price Target: $8
Current: $1.45
Upside: +451.72%
Tango Therapeutics
Jun 29, 2026
Maintained: Buy
Price Target: $42 → $46
Current: $28.73
Upside: +60.11%
Tyra Biosciences
Jun 25, 2026
Maintained: Buy
Price Target: $50
Current: $29.41
Upside: +70.01%
Delcath Systems
Jun 17, 2026
Maintained: Buy
Price Target: $21
Current: $12.91
Upside: +62.66%
Nuvalent
Jun 10, 2026
Downgraded: Hold
Price Target: $126
Current: $123.60
Upside: +1.94%
BridgeBio Oncology Therapeutics
Jun 8, 2026
Maintained: Buy
Price Target: $23
Current: $7.80
Upside: +194.87%
BioNTech SE
Jun 1, 2026
Maintained: Buy
Price Target: $158
Current: $93.92
Upside: +68.23%
Regeneron Pharmaceuticals
May 19, 2026
Maintained: Buy
Price Target: $1,057 → $875
Current: $624.72
Upside: +40.06%
Candel Therapeutics
May 18, 2026
Maintained: Buy
Price Target: $25
Current: $9.88
Upside: +153.04%
May 14, 2026
Maintained: Buy
Price Target: $18
Current: $8.62
Upside: +108.82%
May 14, 2026
Maintained: Buy
Price Target: $14
Current: $2.11
Upside: +563.51%
May 13, 2026
Maintained: Buy
Price Target: $9
Current: $1.30
Upside: +592.31%
May 13, 2026
Maintained: Buy
Price Target: $13
Current: $11.37
Upside: +14.34%
May 6, 2026
Maintained: Buy
Price Target: $38
Current: $15.38
Upside: +147.07%
May 6, 2026
Maintained: Buy
Price Target: $22
Current: $7.94
Upside: +177.08%
Nov 12, 2024
Maintained: Buy
Price Target: $5
Current: $0.9007
Upside: n/a
Nov 12, 2024
Maintained: Buy
Price Target: $10
Current: $4.18
Upside: n/a
Oct 1, 2024
Maintained: Buy
Price Target: $6 → $300
Current: $10.33
Upside: n/a
Aug 8, 2024
Maintained: Buy
Price Target: $43
Current: $10.18
Upside: n/a
May 15, 2024
Maintained: Buy
Price Target: $639.62 → $255.85
Current: $2.14
Upside: n/a
Feb 16, 2022
Maintained: Buy
Price Target: $52 → $44
Current: $37.08
Upside: n/a
Aug 17, 2021
Maintained: Buy
Price Target: $7 → $3
Current: $0.0058
Upside: n/a
May 26, 2021
Maintained: Buy
Price Target: $352.92
Current: $17.60
Upside: n/a
May 12, 2021
Maintained: Buy
Price Target: $31
Current: $24.50
Upside: n/a
May 3, 2021
Maintained: Buy
Price Target: $45
Current: $10.78
Upside: n/a
Mar 25, 2021
Maintained: Buy
Price Target: $5
Current: $0.978
Upside: n/a
Mar 9, 2020
Maintained: Buy
Price Target: $14.21
Current: $9.43
Upside: n/a
Jun 26, 2019
Reiterated: Buy
Price Target: $20
Current: $2.43
Upside: n/a
Aug 13, 2018
Maintained: Buy
Price Target: $31 → $6
Current: $1.45
Upside: n/a
Jun 27, 2017
Reiterated: Buy
Price Target: $8 → $5
Current: $60.30
Upside: n/a
Mar 10, 2017
Reiterated: Buy
Price Target: $10
Current: $15.80
Upside: n/a
Mar 1, 2017
Reiterated: Buy
Price Target: $12
Current: $17.08
Upside: n/a
Dec 30, 2016
Reiterated: Buy
Price Target: $10
Current: $14.81
Upside: n/a
Nov 9, 2016
Reiterated: Buy
Price Target: $6 → $60
Current: $2.11
Upside: n/a
Oct 11, 2016
Reiterated: Buy
Price Target: $6 → $15
Current: $2.46
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $34
Current: $13.81
Upside: n/a
Jul 26, 2016
Reiterated: Buy
Price Target: $3
Current: $6.06
Upside: n/a
Jun 13, 2016
Reiterated: Hold
Price Target: $90
Current: $30.33
Upside: n/a
May 13, 2016
Reiterated: Buy
Price Target: $30
Current: $3.52
Upside: n/a
May 2, 2016
Reiterated: Buy
Price Target: $26
Current: $32.65
Upside: n/a
Mar 31, 2016
Maintained: Buy
Price Target: $18
Current: $1,032.28
Upside: n/a
Mar 9, 2015
Maintained: Hold
Price Target: $8 → $6
Current: $1.05
Upside: n/a
Mar 3, 2015
Reiterated: Buy
Price Target: $201
Current: $237.51
Upside: n/a
Jan 7, 2015
Initiated Coverage: Buy
Price Target: $24
Current: $5.19
Upside: n/a
Oct 7, 2014
Downgraded: Hold
Price Target: $40 → $9
Current: $6.89
Upside: n/a
Dec 20, 2011
Rated: Buy
Price Target: $127
Current: $209.74
Upside: n/a
Mar 15, 2010
Downgraded: Sell
Price Target: $5
Current: $4.05
Upside: n/a
Jun 10, 2009
Maintained: Sell
Price Target: n/a
Current: $81.58
Upside: n/a